dc.contributor.author | Tefekli, A | |
dc.contributor.author | Erol, H | |
dc.contributor.author | Koksal, T | |
dc.contributor.author | Usta, M | |
dc.contributor.author | Kadioglu, A | |
dc.date.accessioned | 2021-03-06T10:03:32Z | |
dc.date.available | 2021-03-06T10:03:32Z | |
dc.date.issued | 2000 | |
dc.identifier.citation | Kadioglu A., Tefekli A., Koksal T., Usta M., Erol H., "Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome", INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, cilt.12, ss.169-175, 2000 | |
dc.identifier.issn | 0955-9930 | |
dc.identifier.other | av_e88537d6-5e39-4ae3-be64-17cb37a360e8 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/152813 | |
dc.identifier.uri | https://doi.org/10.1038/sj.ijir.3900519 | |
dc.description.abstract | As recent clinical and animal studies have indicated, colchicine, with its anti-fibrotic, anti-mitotic and anti-inflammatory activities, has suppressive effects in the pathogenesis of Peyronie's disease. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Nefroloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ÜROLOJİ VE NEFROLOJİ | |
dc.title | Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome | |
dc.type | Makale | |
dc.relation.journal | INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | |
dc.contributor.department | , , | |
dc.identifier.volume | 12 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 169 | |
dc.identifier.endpage | 175 | |
dc.contributor.firstauthorID | 125793 | |